Evidence map›Paper›PMID 31512544›Full record

ArticleEpigenetics2020

No genome-wide DNA methylation changes found associated with medium-term reduced graphene oxide exposure in human lung epithelial cells.

Raúl F Pérez, Anna Yunuen Soto Fernández, Pablo Bousquets Muñoz, Marta I Sierra, Juan Ramón Tejedor, Paula Morales-Sánchez, Adolfo F Valdés, Ricardo Santamaría, Clara Blanco, Ramón Torrecillas and 2 more

Abstract read
In one paragraph

Article in Epigenetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. The Effect of Nanomaterials on DNA Methylation: A Review.Nanomaterials (Basel, Switzerland) · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Raúl F PérezNanomaterials and Nanotechnology Research Center (CINN-CSIC-ISPA), Universidad de Oviedo, El Entrego, Spain.ORCID 0000-0003-4336-9898
Anna Yunuen Soto FernándezCancer Epigenetics Laboratory, Instituto de Oncología de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain.
Pablo Bousquets MuñozCancer Epigenetics Laboratory, Instituto de Oncología de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain.ORCID 0000-0002-2969-008X
Marta I SierraCancer Epigenetics Laboratory, Instituto de Oncología de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain.
Juan Ramón TejedorCancer Epigenetics Laboratory, Instituto de Oncología de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain.ORCID 0000-0002-4061-9698
Paula Morales-SánchezCancer Epigenetics Laboratory, Instituto de Oncología de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain.ORCID 0000-0002-9563-668X
Adolfo F ValdésNanomaterials and Nanotechnology Research Center (CINN-CSIC-ISPA), Universidad de Oviedo, El Entrego, Spain.
Ricardo SantamaríaDepartment of Chemistry of Materials, INCAR-CSIC-ISPA, Oviedo, Spain.
Clara BlancoDepartment of Chemistry of Materials, INCAR-CSIC-ISPA, Oviedo, Spain.
Ramón TorrecillasNanomaterials and Nanotechnology Research Center (CINN-CSIC-ISPA), Universidad de Oviedo, El Entrego, Spain.ORCID 0000-0003-3856-0217
Mario F FragaNanomaterials and Nanotechnology Research Center (CINN-CSIC-ISPA), Universidad de Oviedo, El Entrego, Spain.ORCID 0000-0001-8450-2603
Agustín F FernándezCancer Epigenetics Laboratory, Instituto de Oncología de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain.ORCID 0000-0002-3792-4085

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presence of nanomaterials in our everyday life is ever increasing, and so too are concerns about the possible health consequences of exposure to them. While evidence of their biological activity is growing, there is still scant knowledge of the epigenetic mechanisms that could be at play in these processes. Moreover, the great variability in the chemical and physical structures of these compounds handicaps the study of their possible health risks. Here we have synthesized reduced graphene oxide (rGO) through the thermal exfoliation/reduction of graphite oxide, and characterized the resulting material. We have then made use of Illumina's MethylationEPIC arrays and bisulphite pyrosequencing to analyse the genome-wide and global DNA methylation dynamics associated with the medium-term exposure of human lung epithelial cells to rGO at concentrations of 1 and 10 µg/mL. The results show no genome-wide or global DNA methylation changes associated with either condition. Our observations thus suggest that medium-term rGO exposure does not have significant effects on the DNA methylation patterns of human lung epithelial cells.

Indexed as

DNA MethylationEpigenomeAlveolar Epithelial CellsCells, CulturedGraphiteHumansNanostructuresgraphene oxideGraphiteDNA methylationEpigeneticsexposuregraphenenanomaterials

Identifiers

PMID31512544
PMCPMC7028337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.